Form 4: Scholar Rock CMO Sells Shares for Tax Obligation
Insider Transaction Report
Scholar Rock's Chief Medical Officer, Jing L. Marantz, sold 5,798 shares of common stock at $44.4777 per share to cover tax withholding obligations related to vested restricted stock units.
Summary
- Jing L. Marantz, Chief Medical Officer of Scholar Rock Holding Corp (SRRK), reported a sale of 5,798 shares of common stock.
- The transaction occurred on January 16, 2026, at a price of $44.4777 per share.
- This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to fund tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- The sale does not represent a discretionary trade by the Reporting Person.
- The RSUs, which vested on January 15, 2026, were granted on February 12, 2024.
- Following this transaction, Jing L. Marantz beneficially owns 95,687 shares, consisting of 24,974 shares of common stock and 70,713 RSUs.
Sentiment
Score: 5
Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which does not reflect a positive or negative sentiment towards the company's prospects.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction report is a routine disclosure for publicly traded companies, reflecting a standard 'sell to cover' event for executive compensation. It does not provide specific insights into broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or strategic direction.
Key Dates
| Date | Description |
|---|---|
| 02/12/2024 | Date when restricted stock unit (RSU) awards were granted to Jing L. Marantz. |
| 01/15/2026 | Date when restricted stock units (RSUs) vested, triggering the tax withholding obligation. |
| 01/16/2026 | Date of the reported transaction where 5,798 shares were sold to cover tax withholding. |
| 01/21/2026 | Date the Form 4 was signed by the Attorney-in-Fact for Jing L. Marantz. |
Keywords
Scholar Rock, SRRK, Form 4, Insider Transaction, Stock Sale, RSU, Chief Medical Officer, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.